文献速递糖尿病

HypoA-Q/IA量表与Gold及Clarke低血糖感知受损评估的对应切点探索:Hypo-METRICS研究事后分析

Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire (HypoA‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐METRICS Study
RSS 订阅 · Diabetes, Obesity and Metabolism · 2026-11-04

本研究基于Hypo-METRICS现实世界观察性研究,纳入232例1型糖尿病和285例接受胰岛素治疗的2型糖尿病患者,采用双向ROC分析探索HypoA-Q/IA与Gold及Clarke量表的对应切点。结果显示,与Gold≥4和Clarke≥4对应的HypoA-Q/IA切点分别为≥7和≥9,均低于钳夹研究得出的≥12阈值。

要点

  • HypoA-Q/IA与Gold及Clarke的对应切点为7-9,低于钳夹研究得出的12。
  • HypoA-Q/IA≥12可能识别更严重的低血糖感知受损亚组。
  • 两种方法均识别的IAH重叠比例在2型糖尿病中低于1型糖尿病。

核心结论

  • 与Gold和Clarke传统切点对应的HypoA-Q/IA切点为7-9,低于钳夹研究得出的12,提示12可能识别更严重的IAH亚组。

研究设计与样本

  • Hypo-METRICS研究的事后分析,纳入232例1型糖尿病和285例2型糖尿病(接受胰岛素治疗且近3个月至少1次低血糖事件)患者。
  • 采用双向ROC分析探索HypoA-Q/IA与Gold及Clarke切点之间的对应关系。

主要发现

  • IAH患病率按Gold≥4为24%,按Clarke≥4为16%,按HypoA-Q/IA≥12为7%。
  • HypoA-Q/IA对Gold≥4的切点为≥7(AUC 0.87),对Clarke≥4的切点为≥9(AUC 0.89)。
  • Gold≥4对HypoA-Q/IA≥12的AUC为0.87,Clarke≥3对HypoA-Q/IA≥12的AUC为0.93。
  • 在任一方法判定IAH的患者中,24%同时满足HypoA-Q/IA≥12和Gold≥4,32%同时满足HypoA-Q/IA≥12和Clarke≥4。
  • 两种方法的重叠比例在2型糖尿病中低于1型糖尿病。

关键数值与推荐

  • IAH定义:Gold≥4、Clarke≥4和/或HypoA-Q/IA≥12。
  • 与Gold≥4对应的HypoA-Q/IA切点为≥7(AUC 0.87),与Clarke≥4对应的切点为≥9(AUC 0.89)。

临床怎么用

  • 临床中可使用HypoA-Q/IA≥7-9作为与传统量表对应的IAH筛查切点,便于跨研究比较。
  • HypoA-Q/IA≥12可能用于识别更严重的IAH患者,但需前瞻性验证其与严重低血糖风险的关系。

局限性

  • 本研究为事后分析,切点需在前瞻性研究中验证其与严重低血糖风险的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Aims The Hypoglycaemia Awareness Questionnaire–Impaired Awareness subscale (HypoA-Q/IA) was developed to enhance impaired awareness of hypoglycaemia (IAH) assessment, addressing methodological deficiencies of the established Gold and Clarke measures. An IAH cutpoint (HypoA-Q/IA ≥ 12) was identified from a clamp study in Type 1 diabetes (T1D). We explored cutpoints in relation to Gold and Clarke measures, and their co-occurrence, in the larger, real-world observational Hypo-METRICS study, in people with T1D (pwT1D) and insulin-treated Type 2 diabetes (pwT2D). Material and Methods Hypo-METRICS recruited pwT1D or pwT2D with ≥ 1 hypoglycaemic event in the previous 3 months. IAH was defined as Gold ≥ 4, Clarke ≥ 4 and/or HypoA-Q/IA ≥ 12. Bidirectional ROC analysis was performed between HypoA-Q/IA and Gold/Clarke cutpoints. Results Questionnaires were completed by 232 pwT1D and 285 pwT2D (male 47% vs. 62%, p < 0.001; median age 49 vs. 63 years, p < 0.001; HbA1c 7.3% vs. 7.4%, p = 0.03). IAH prevalence was 24% by Gold ≥ 4, 16% by Clarke ≥ 4 and 7% by HypoA-Q/IA ≥ 12. ROC analysis yielded HypoA-Q/IA cutpoints of ≥ 7 against Gold ≥ 4 (AUC 0.87) and ≥ 9 against Clarke ≥ 4 (AUC 0.89), and cutpoints of Gold ≥ 4 (AUC 0.87) and Clarke ≥ 3 (AUC 0.93) against HypoA-Q/IA ≥ 12. Of those with IAH by either measure, 24% were identified by both HypoA-Q/IA ≥ 12 and Gold ≥ 4, and 32% by both HypoA-Q/IA ≥ 12 and Clarke ≥ 4, with lower overlap in T2D than T1D. Conclusions HypoA-Q/IA cutpoints corresponding to legacy IAH cutpoints (≥ 7–9) were lower than the clamp-derived threshold (≥ 12), suggesting ≥ 12 may identify a subgroup with more severe IAH. These cutpoints enable cross-study comparison; prospective validation against severe hypoglycaemia risk is needed.

来源:Diabetes, Obesity and Metabolism,查看原文。版权归原作者所有。

引用

  1. Diabetes, Obesity and Metabolism:Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire (HypoA‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐METRICS Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。